At the time of writing, Revolution Medicines Inc [RVMD] stock is trading at $45.14, up 4.13%. An important factor to consider is whether the stock is rising or falling in short-term value. The RVMD shares have gain 20.28% over the last week, with a monthly amount glided 15.68%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Revolution Medicines Inc [NASDAQ: RVMD] stock has seen the most recent analyst activity on July 12, 2024, when Barclays initiated its Overweight rating and assigned the stock a price target of $52. Previously, Jefferies started tracking the stock with Buy rating on July 08, 2024, and set its price target to $63. On April 12, 2024, Needham reiterated its Buy rating and revised its price target to $46 on the stock. Raymond James upgraded its rating to a Strong Buy and increased its price target to $48 on April 10, 2024. Piper Sandler initiated its recommendation with a Overweight and recommended $43 as its price target on March 11, 2024. BofA Securities upgraded its rating to Buy for this stock on January 05, 2024, and upped its price target to $34. In a note dated January 04, 2024, Wedbush initiated an Outperform rating and provided a target price of $41 on this stock.
For the past year, the stock price of Revolution Medicines Inc fluctuated between $15.44 and $44.80. Currently, Wall Street analysts expect the stock to reach $45.5 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $45.14 at the most recent close of the market. An investor can expect a potential return of 0.8% based on the average RVMD price forecast.
Analyzing the RVMD fundamentals
According to Revolution Medicines Inc [NASDAQ:RVMD], the company’s sales were 4.57M for trailing twelve months, which represents an -100.00% plunge. Gross Profit Margin for this corporation currently stands at -1.09% with Operating Profit Margin at -121.09%, Pretax Profit Margin comes in at -106.83%, and Net Profit Margin reading is -106.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.36 and Total Capital is -0.3. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 43.85 points at the first support level, and at 42.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 45.84, and for the 2nd resistance point, it is at 46.55.
Ratios To Look Out For
It is important to note that Revolution Medicines Inc [NASDAQ:RVMD] has a current ratio of 18.45. On the other hand, the Quick Ratio is 18.45, and the Cash Ratio is 3.08. Considering the valuation of this stock, the price to sales ratio is 1629.68, the price to book ratio is 4.31.
Transactions by insiders
Recent insider trading involved Cislini Jeff, General Counsel, that happened on Jul 09 ’24 when 2399.0 shares were sold. Director, Patel Sushil completed a deal on Jul 09 ’24 to sell 2155.0 shares. Meanwhile, General Counsel Cislini Jeff sold 2000.0 shares on Jun 26 ’24.
